ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ARQT Company Profile and Key Details

NASDAQ : ARQT

Arcutis Biotherapeutics, Inc.

$16.60

1.62+10.81%

At Close 4:00 PM

71.67

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ARQT Stock Price Chart

Stock Price Today

Arcutis Biotherapeutics, Inc. (ARQT) stock surged +10.81%, trading at $16.60 on NASDAQ, up from the previous close of $14.98. The stock opened at $14.61, fluctuating between $14.56 and $17.42 in the recent session.

Stock Snapshot

14.98

Prev. Close

14.61

Open

1.97B

Market Cap

118.64M

Number of Shares

14.56

Day Low

17.42

Day High

-14.31

P/E Ratio

87.99%

Free Float in %

-1.16

EPS (TTM)

0.96

Book Value

-2.67

Cash Flow per Share

5.37M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	14.61	17.43	14.51	16.60	5.35M
Apr 01, 2025	15.57	15.57	14.81	14.98	1.46M
Mar 31, 2025	15.10	16.11	14.76	15.62	2.94M
Mar 28, 2025	16.00	16.27	15.41	15.73	1.45M
Mar 27, 2025	16.39	16.62	15.96	16.09	1.46M
Mar 26, 2025	17.12	17.55	16.38	16.47	1.56M
Mar 25, 2025	17.64	17.75	16.80	17.11	3.09M
Mar 24, 2025	17.30	17.64	16.91	17.29	2.48M
Mar 21, 2025	16.62	17.12	16.27	17.01	1.97M
Mar 20, 2025	16.70	17.50	16.63	16.77	3.29M
Mar 19, 2025	16.03	16.85	15.70	16.60	2.41M
Mar 18, 2025	16.24	16.35	15.45	15.87	3.44M
Mar 17, 2025	14.69	17.70	14.26	16.42	8.83M
Mar 14, 2025	14.87	15.38	14.51	14.62	1.69M
Mar 13, 2025	15.12	15.40	14.63	14.82	1.04M
Mar 12, 2025	15.76	16.09	14.73	15.16	2.33M
Mar 11, 2025	14.39	15.50	14.16	15.49	2.58M
Mar 10, 2025	14.32	14.73	14.14	14.40	1.81M
Mar 07, 2025	14.50	14.86	13.80	14.72	1.5M
Mar 06, 2025	14.53	15.10	14.24	14.50	2.07M

Contact Details

Westlake Village, CA 91361

United States

Website: https://www.arcutis.comContact: 805 418 5006

About Company

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Frequently Asked Questions

What is the current Arcutis Biotherapeutics, Inc. (ARQT) stock price?

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) stock price is $16.60 in the last trading session. During the trading session, ARQT stock reached the peak price of $17.42 while $14.56 was the lowest point it dropped to. The percentage change in ARQT stock occurred in the recent session was 10.81% while the dollar amount for the price change in ARQT stock was $1.62.

ARQT's industry and sector of operation?

The NASDAQ listed ARQT is part of Biotechnology industry that operates in the broader Healthcare sector. Arcutis Biotherapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ARQT?

Mr. Kenneth A. Lock
Senior Vice President & Chief Commercial Officer
Dr. David W. Osborne Ph.D.
Chief Technical Officer
Mr. Matthew Richard Moore
Senior Vice President & Chief Bus. Officer
Mr. Scott L. Burrows
Chief Financial Officer, Principal Accounting Officer & Senior Vice President
Mr. Rajvir Madan
Chief Digital & Technology Officer
Ms. Kimberly Lathroum
Vice President of Marketing
Mr. Todd Franklin Watanabe M.A.
Pres, Chief Executive Officer & Director
Dr. Bhaskar Chaudhuri Ph.D.
Co-Founder & Independent Director
Dr. Patrick E. Burnett M.D., Ph.D.
Senior Vice President & Chief Medical Officer
Mr. Eric McIntyre
Head of Investor Relations
Ms. Courtney Barton
Vice President and Chief Compliance Officer & Privacy Officer
Ms. Amanda Sheldon
Head of Corporation Communications
Mr. Masaru Matsuda Esq., J.D.
Senior Vice President, Gen. Counsel & Corporation Sec.
Ms. Patricia A. Turney
Senior Vice President of Operations

How ARQT did perform over past 52-week?

ARQT's closing price is 137.48% higher than its 52-week low of $6.99 where as its distance from 52-week high of $17.75 is -6.48%.

How many employees does ARQT have?

Number of ARQT employees currently stands at 342.

Link for ARQT official website?

Official Website of ARQT is: https://www.arcutis.com

How do I contact ARQT?

ARQT could be contacted at phone 805 418 5006 and can also be accessed through its website. ARQT operates from 3027 Townsgate Road, Westlake Village, CA 91361, United States.

How many shares of ARQT are traded daily?

ARQT stock volume for the day was 5.37M shares. The average number of ARQT shares traded daily for last 3 months was 2.33M.

What is the market cap of ARQT currently?

The market value of ARQT currently stands at $1.97B with its latest stock price at $16.60 and 118.64M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	342
Beta	1.49
Sales or Revenue	$59.61M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology